HighLife
HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.
€80MFinancing round
LeadActivity from announced rounds
Pitching Mérieux Equity Partners? Send the deck from a free RoundOS data room and see which pages they read.